Funding
Sponsorship for this study was funded by Eli Lilly Japan K.K., Kobe, Japan, the manufacturer of baricitinib. Publication Processing Fee (Rapid Service Fee and Open Access) for the journal was funded by Eli Lilly Japan and Daiichi Sankyo Company, Limited.